Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

BACKGROUND: Prescription opioids (POs) are commonly used to treat moderate to severe chronic pain in the health system setting. Although they improve quality of life for many patients, more work is needed to identify both the clinical and genetic factors that put certain individuals at high risk for...

Descripción completa

Detalles Bibliográficos
Autores principales: Troiani, Vanessa, Crist, Richard C., Doyle, Glenn A., Ferraro, Thomas N., Beiler, Donielle, Ranck, Stephanie, McBryan, Kortney, Jarvis, Margaret A., Barbour, Jordan S., Han, John J., Ness, Ryan J., Berrettini, Wade H., Robishaw, Janet D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547564/
https://www.ncbi.nlm.nih.gov/pubmed/34702274
http://dx.doi.org/10.1186/s12920-021-01100-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547564/
https://www.ncbi.nlm.nih.gov/pubmed/34702274
http://dx.doi.org/10.1186/s12920-021-01100-z

Ejemplares similares